SGLT2i Use Linked to Reduced Risk for Flare in Adults With Gout, T2D
MONDAY, July 24, 2023 (HealthDay News) -- For patients with gout and type 2 diabetes, sodium-glucose cotransporter-2 inhibitors (SGLT2is) are associated with a reduced risk for recurrent gout flares and gout-primary emergency department visits and hospitalizations, and they confer cardiovascular benefits, according to a study published online July 25 in the Annals of Internal Medicine.
Natalie McCormick, Ph.D., from Massachusetts General Hospital in Boston, and colleagues compared gout flares and cardiovascular events among patients with gout and type 2 diabetes initiating SGLT2is versus dipeptidyl peptidase 4 inhibitors (DPP-4is) in a propensity score-matched cohort study.
The researchers found that the flare rate was lower among SGLT2i initiators than DPP-4i initiators after propensity score matching (52.4 versus 79.7 events per 1,000 person-years, respectively; rate ratio [RR], 0.66; rate difference [RD], −27.4 per 1,000 person-years). For gout-primary emergency department visits and hospitalizations, the corresponding RR and RD were 0.52 and −3.4 per 1,000 person-years. For myocardial infarction, the corresponding hazard ratio and RD were 0.69 and −7.6 per 1,000 person-years. The hazard ratio for stroke was not significantly lower. A higher risk for genital infection was seen for those who initiated SGLT2is (hazard ratio, 2.15); the risk for osteoarthritis encounter was not altered.
"Given the pleiotropic cardiometabolic benefits associated with SGLT2is among patients with type 2 diabetes, this class of medications may be a particularly attractive addition to our current urate-lowering therapies to simultaneously address the high burden of gout and cardiometabolic sequelae," the authors write.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Hormonal Treatment in Pregnancy Won’t Lower Odds for Preterm Birth
WEDNESDAY, Nov. 2, 2022 (HealthDay News) -- A hormone therapy commonly used to...
Sex Hormone Deficiency May Up Risk for Rotator Cuff Repair
THURSDAY, April 21, 2022 (HealthDay News) -- Sex hormone deficiency is...
Sleep Meds Tied to Higher Dementia Risk in White Older Adults
THURSDAY, Feb. 16, 2023 (HealthDay News) -- Frequent sleep medication use is...
Trends in Pediatric ED Visits for Mental Health Conditions Explored
WEDNESDAY, Feb. 23, 2022 (HealthDay News) -- Compared with 2019, there were...